Galectin's belapectin + Keytruda enhances tumor response in melanoma, head/neck cancer
April 14 2021 - 12:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Apr 2023 to Apr 2024